Have your own idea? Try our Stock Screener
Argentinian (MERVAL) Pharma Industry Analysis
UpdatedNov 14, 2024
DataAggregated Company Financials
Companies2
- 7D2.4%
- 3M73.7%
- 1Y175.6%
- YTDn/a
In the last week, the Pharma industry is up 13%, with Laboratorios RichmondC.I.F up 14%. In the last 12 months, the industry was up 141%.
Industry Valuation and Performance
Has the Argentinian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 14 Nov 2024 | AR$151.9b | AR$42.6b | AR$18.2b | 6.2x | 8.4x | 3.6x |
| Sat, 12 Oct 2024 | AR$79.3b | AR$40.7b | AR$4.6b | 12.6x | 17.4x | 1.9x |
| Mon, 09 Sep 2024 | AR$77.7b | AR$40.7b | AR$4.6b | 12.5x | 17.1x | 1.9x |
| Wed, 07 Aug 2024 | AR$80.2b | AR$41.1b | -AR$3,264,658,797.00 | 3.9x | -24.6x | 2x |
| Fri, 05 Jul 2024 | AR$84.6b | AR$41.1b | -AR$3,264,658,797.00 | 4.9x | -25.9x | 2.1x |
| Sun, 02 Jun 2024 | AR$86.7b | AR$41.1b | -AR$3,264,658,797.00 | 5x | -26.5x | 2.1x |
| Tue, 30 Apr 2024 | AR$74.9b | AR$43.6b | -AR$10,287,966,966.00 | 6.7x | -7.3x | 1.7x |
| Thu, 28 Mar 2024 | AR$73.6b | AR$9.6b | -AR$4,702,241,388.00 | 59.8x | -15.6x | 7.6x |
| Sat, 24 Feb 2024 | AR$76.4b | AR$9.6b | -AR$4,702,241,388.00 | 55.9x | -16.2x | 7.9x |
| Mon, 22 Jan 2024 | AR$70.4b | AR$10.3b | -AR$4,704,193,685.00 | 37.2x | -15x | 6.8x |
| Wed, 20 Dec 2023 | AR$61.2b | AR$10.3b | -AR$4,704,193,685.00 | 34.2x | -13x | 5.9x |
| Fri, 17 Nov 2023 | AR$52.3b | AR$13.0b | -AR$2,496,856,221.00 | n/a | -21x | 4x |
| Sun, 15 Oct 2023 | AR$51.1b | AR$13.0b | -AR$2,496,856,221.00 | n/a | -20.5x | 3.9x |
| Tue, 12 Sep 2023 | AR$43.1b | AR$18.8b | -AR$150,001,147.00 | 17.2x | -287.6x | 2.3x |
| Thu, 10 Aug 2023 | AR$43.4b | AR$18.8b | -AR$150,001,147.00 | 12.9x | -289.1x | 2.3x |
| Sat, 08 Jul 2023 | AR$41.6b | AR$18.8b | -AR$150,001,147.00 | 13.5x | -277.6x | 2.2x |
| Mon, 05 Jun 2023 | AR$41.4b | AR$19.1b | AR$209.1m | 133.3x | 197.9x | 2.2x |
| Wed, 03 May 2023 | AR$33.5b | AR$19.1b | AR$209.1m | 107.4x | 160.2x | 1.8x |
| Fri, 31 Mar 2023 | AR$32.4b | AR$19.1b | AR$209.1m | 103.9x | 155x | 1.7x |
| Sun, 26 Feb 2023 | AR$32.1b | AR$13.7b | AR$1.5b | 17.2x | 20.7x | 2.3x |
| Tue, 24 Jan 2023 | AR$31.7b | AR$13.7b | AR$1.5b | 17x | 20.5x | 2.3x |
| Thu, 22 Dec 2022 | AR$29.3b | AR$13.8b | AR$1.5b | 19.2x | 19.5x | 2.1x |
| Sat, 19 Nov 2022 | AR$26.7b | AR$19.6b | AR$1.4b | 19.2x | 19.6x | 1.4x |
| Mon, 17 Oct 2022 | AR$28.6b | AR$19.7b | AR$1.4b | 24.7x | 20.7x | 1.5x |
| Wed, 14 Sep 2022 | AR$25.3b | AR$19.7b | AR$1.4b | 24.5x | 18.3x | 1.3x |
| Fri, 12 Aug 2022 | AR$22.6b | AR$17.8b | AR$987.0m | 25.6x | 22.9x | 1.3x |
| Sun, 10 Jul 2022 | AR$20.9b | AR$9.9b | AR$101.3m | 157.5x | 206.1x | 2.1x |
| Tue, 07 Jun 2022 | AR$19.5b | AR$9.9b | AR$101.3m | 146.9x | 192.6x | 2x |
| Thu, 05 May 2022 | AR$20.0b | AR$9.9b | AR$101.3m | 151.1x | 197.7x | 2x |
| Sat, 02 Apr 2022 | AR$20.1b | AR$9.9b | AR$101.3m | 151.2x | 198.4x | 2x |
| Mon, 28 Feb 2022 | AR$21.1b | AR$9.9b | AR$101.3m | 158.1x | 208.4x | 2.1x |
| Wed, 26 Jan 2022 | AR$18.7b | AR$9.9b | AR$101.3m | 140.7x | 185x | 1.9x |
| Fri, 24 Dec 2021 | AR$19.8b | AR$9.9b | AR$101.3m | 148.8x | 195.2x | 2x |
| Sun, 21 Nov 2021 | AR$19.7b | AR$7.0b | AR$393.1m | 46.1x | 50.1x | 2.8x |
Price to Earnings Ratio
50.1x
Current Industry PE
- There are only 2 companies in the Argentinean Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 126% per year over the last three years.
- Revenues for these companies have grown 79% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Argentinian Pharma compare with similar industries?
| AR Market | 3.31% | |
| Healthcare | 2.42% | |
| Pharma | 2.42% | |
| Pharma | 2.42% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| RICH Laboratorios RichmondC.I.F | AR$1.75k | 2.3% +AR$3.2b | 177.8% | PE8.2x | |
| ROSE Instituto Rosenbusch | AR$100.00 | 5.3% +AR$212.9m | 115.1% | PE4.3x |